COPD Board decisions

The Board denied service connection for hepatic stenosis, COPD, CHF, and depression, as well as a compensable rating for bilateral hearing loss.

The Board granted an earlier effective date of April 3, 2018 for the grant of service connection for obstructive sleep apnea and a 100 percent disability rating from that date.

The Board remands the claims for an increased rating for sarcoidosis with OSA and an initial compensable rating for chronic bronchitis with COPD to obtain additional evidence.

The Board dismissed the appeal for service connection for an acquired psychiatric disorder and a TDIU due to improper concurrent election of review options, and denied service connection for COPD as there is no current diagnosis.

The Board granted service connection for congestive heart failure (CHF) and remanded the claims for hypertension, pleurisy, and chronic obstructive pulmonary disease (COPD).

The Board granted service connection for a left knee disability, right knee disability on a secondary basis, obstructive sleep apnea on a secondary basis, psychiatric disorder on a secondary basis, diabetes mellitus type 2 (diabetes) on a secondary basis, and hypertension on a secondary basis.

The Board granted an initial rating of 100 percent for COPD with asthma from July 23, 2012, to May 21, 2019, and a 60 percent rating as of May 22, 2019. The claim for an initial rating over 30 percent for left eye amblyopia was denied.

The Board denied service connection for a digestive disability, an acquired psychiatric disorder, and chronic obstructive pulmonary disease (COPD) as the evidence did not support a finding that these conditions were related to the Veteran's active duty.

The Veteran withdrew his appeal for all service connection and increased rating claims, resulting in the dismissal of these matters without prejudice.

The Veteran withdrew his appeal at the Board hearing, and the appeal is dismissed.

The 100 percent rating for lung cancer was discontinued effective November 1, 2024, as the Veteran's lung cancer is in remission and no longer active. The claim for a compensable disability rating for lung cancer residuals has been remanded.

The Board remands the claim for service connection for DIC as new and relevant evidence was submitted after the August 2007 rating decision.

The Veteran's respiratory disability was granted a 100 percent rating from December 27, 2023, and the TDIU claim prior to that date was denied.

The Board denied the Veteran's claim for service connection for a respiratory condition, including COPD, due to in-service ammonia inhalation and herbicide exposure.

The Board remands the claim for a respiratory disability, to include COPD, chronic bronchitis, and asthma, for an addendum opinion addressing the etiology of the Veteran's condition.

The Board denied service connection for COPD, atrial fibrillation, squamous cell carcinoma, lymphosarcoma, and lung cancer as they were not related to the Veteran's military service.

The Board remands the claim for a recurrent pulmonary disability to ensure that there is a complete record upon which to decide the claim, including obtaining a thorough and contemporaneous medical examination.

The Board dismissed the appeal for service connection for COPD and denied earlier effective dates on a presumptive basis for diabetes mellitus, but granted an earlier effective date for coronary artery disease. The Board also granted an increased rating from August 10, 2022 for diabetes mellitus.

The Board granted service connection for chronic obstructive pulmonary disease (COPD) based on the evidence being at least evenly balanced as to whether it is related to toxic exposures during active duty.

The Board granted service connection for lung scarring and remanded the other issues for further development.